Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - COST OF REVENUE
Cost of Revenue EXEL - Exelixis, Inc.
72.5 M
LAST VALUE
17.14%
2 YEAR CAGR
22.45%
5 YEAR CAGR
51.78%
10 YEAR CAGR